Katz, M., Varadhachary, G., Fleming, J., Wolff, R., Lee, J., Pisters, P., . . . Evans, D. (2010). Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation.
Chicago Style (17th ed.) CitationKatz, Matthew, et al. Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation. 2010.
MLA (9th ed.) CitationKatz, Matthew, et al. Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation. 2010.
Warning: These citations may not always be 100% accurate.